UFPT logo

UFP Technologies Inc. (UFPT)

$286

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on UFPT

Market cap

$2.22B

EPS

9.25

P/E ratio

31.2

Price to sales

3.54

Dividend yield

--

Beta

1.032061

Price on UFPT

Previous close

$294.84

Today's open

$291.13

Day's range

$283.20 - $295.25

52 week range

$173.86 - $338.71

Profile about UFPT

CEO

R. Jeffrey Bailly

Employees

4146

Headquarters

Newburyport, MA

Exchange

NASDAQ Capital Market

Shares outstanding

7745790

Issue type

Common Stock

UFPT industries and sectors

Healthcare

Medical Equipment & Supplies

News on UFPT

UFP Technologies to Report Third Quarter 2026 Financial Results on November 3, 2026

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the third quarter on Tuesday, November 3rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, November 4.

news source

Business Wire • 10 hours ago

news preview

Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity

Utz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health declined during the quarter as selling pressure emerged following a strong first half of 2026. We initiated a position in Bank7, given its highly profitable, branch-light model and recent acquisition of Century Bank, which we believe should meaningfully enhance earnings.

news source

Seeking Alpha • Oct 28, 2026

news preview

Implied Volatility Surging for UFP Technologies Stock Options

Investors need to pay close attention to UFPT stock based on the movements in the options market lately.

news source

Zacks Investment Research • Sep 9, 2026

news preview

3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes

GenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likely to challenge adoption across healthcare.

news source

Zacks Investment Research • Sep 9, 2026

news preview

UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares

The sale represents a total value of $324,260. The disposition was executed entirely through direct ownership, leaving the insider with 4,476 shares held directly.

news source

The Motley Fool • Aug 31, 2026

news preview

UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds

UFP Technologies NASDAQ: UFPT outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving medical-device companies.

news source

MarketBeat • Aug 28, 2026

news preview

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), today announced Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present and host 1-on-1 meetings at the Midwest IDEAS Investor Conference on Wednesday, August 26, 2026 at The InterContinental in Chicago, IL. The company's presentation is scheduled to begin at 8:35 AM CT. The presentation is webcast and can be accessed through the con.

news source

Business Wire • Aug 20, 2026

news preview

Why UFP Technologies Stock Is Skyrocketing Today

UFP Technologies grew sales and adjusted earnings per share by 15% and 17% in the second quarter. This was even though its largest product category -- robotic surgery drapes -- was largely flat.

news source

The Motley Fool • Aug 4, 2026

news preview

UFP Technologies Q2 Earnings Call Highlights

UFP Technologies NASDAQ: UFPT reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per share rose 16.8% to a company-record $2.92.

news source

MarketBeat • Aug 4, 2026

news preview

UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript

UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 4, 2026

news preview

¹ Disclosures

Get started with M1

Invest in UFP Technologies Inc.

Open an M1 investment account to buy and sell UFP Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in UFPT on M1